Specimen Model Project: Requirements from Clinical Genomics Mukesh Sharma Washington University Medical School St. Louis October 2010 WG meeting.

Slides:



Advertisements
Similar presentations
Helmut König, Siemens Medical Solutions
Advertisements

1 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update JOINT RCRIM and CG Session CTLAB Message Pharmacogenomics Results Overview.
HL7 Clinical Genomics and Structured Documents Work Groups CDA Implementation Guide: Genetic Testing Report DRAFT PROPOSAL Amnon Shabo (Shvo), PhD
Legal Work Group Developing a Uniform EHR/HIE Patient Consent Form.
Electronic Submission of Medical Documentation (esMD) eDoC Administrative Documents Templates for HL7 Orders October 25, 2013.
Making assumption that Organism = living biological plant/animal/microbe… that is studied. Therefore “Sample type” renamed “Organism type” Also making.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 4e Basic Health Data Standards Component 9/Unit.
Brief review of what Crimson does Scope of the i2b2 Crimson cell –(1) i2b2 sample ontology + ontology management for source LIMS broadcasting samples to.
The Veterans Affairs Central Biorepository and MVP Highlights Mary T
Clinical Genomics Work Group (HL7) Mukesh Sharma Washington University in St. Louis.
Quality Management within the Clinical Research Process
HIPAA – Privacy Rule and Research USCRF Research Educational Series March 19, 2003.
New Features in caTissue Suite 1.2: Storage Container, Diagnosis, Saved Queries, Key Word Search and Auto Labeling Amy Brink/Dave Mulvihill Tissue/Biospecimen.
Virginia Child ID Program and Implementation at Inova Health System
Chapters 7 & 9 System Scope
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Tissue Banking Marilyn Mason, Ph.D. January 14, 2009.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Using EDC-Rave to Conduct Clinical Trials at Genentech
Organizing IHE Integration Profiles related to the Electronic Health Record Input to the IHE ITI Tech Committee November 2002 Charles Parisot, GE Medical.
Collecting Stool Specimens
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.
Relational Database Concepts. Let’s start with a simple example of a database application Assume that you want to keep track of your clients’ names, addresses,
December 2006 MAGE and the Biospecimen Research Database Experiment Design and other issues Ian Fore, D.Phil U.S. National Cancer Institute - Center for.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Integrated Biomedical Information for Better Health Workprogramme Call 4 IST Conference- Networking Session.
Clinical Genomics Joint with RCRIM Amnon Shabo Joyce Hernandez Mukesh Sharma.
Joyce Mull, MPM Director, Regulatory Affairs National Surgical Adjuvant Breast and Bowel Project Consent Form and IRB Challenges that Arise with Specimen.
BNR – Stroke: data entry and data management CAREC/PAHO Curacoa,15-16 November 2010 Gina Pitts, BNR-CVD Registrar Chronic Disease Research Centre, Jemmotts.
Expedited Review – Retrospective studies: A New Path Stephanie Gentilin, MA, CCRAKatherine Bright Director SCTR SUCCESS Center, eIRB Team MemberIRB, Grants.
1 LS DAM Overview and the Specimen Core February 16, 2012 Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Elaine Freund,
GENOMIC RESEARCH: INFORMED CONSENT. Genomics- a branch of genetics that sequences DNA to analyze the structure and function of genomes (the complete set.
Step What happens?. Who is responsible? Procedures needed?
Sept 13-15, 2004IHE Interoperability Workshop 1 Integrating the Healthcare Enterprise Status of IHE Laboratory Francois Macary, GWI Medica France Charles.
Phlebotomy Technician Medical Lab Assistant Medical Lab Technician Medical Technologist/Clinical Lab Scientist.
IHE Workshop – June 2007What IHE Delivers 1 Nicholas Steblay Boston Scientific Implantable Device Cardiac Observations (IDCO) Profile.
IHE Update IT Infrastructure, Radiology, Laboratory and Cardiology IHE Update to December 2003 DICOM Committee Charles Parisot, GE Medical Systems Information.
Transfusion Medicine Transport of Blood, Blood Components and Derivatives within a Facility DSM Educational Resource Materials for the Training of Facility.
Commentary: The HL7 Reference Information Model as the Basis for Interoperability George W. Beeler, Jr. Ph.D. Co-Chair, HL7 Modeling & Methodology.
Unit: Ethical and Legal.   Client Autonomy  The right of patients to make decisions about their medical care without their health care provider trying.
24 Nov 2007Data Management and Exploratory Data Analysis 1 Yongyuth Chaiyapong Ph.D. (Mathematical Statistics) Department of Statistics Faculty of Science.
CDA Overview HL7 CDA IHE Meeting, February 5, 2002 Slides from Liora Alschuler, alschuler.spinosa Co-chair HL7.
EMERGENCY MEDICAL EVALUATION DESCRIPTION  Respond to emergency situations which arise in the vaccination clinic: assess the condition of the patient and.
1 LS DAM Overview August 7, 2012 Current Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Mervi Heiskanen, NCI-CBIIT, Joyce.
CaTissue Suite 1.2 TPBT Face to Face Michelle Lee, MBA, Ph.D. Ian Fore, D. Phil. December, 2009.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Retention period(s) of samples/data Many jurisdictions, as well as hospitals and institutions, mandate retention periods for medical or research-related.
Global Specimen Identifiers TBPT Workspace Call 19 July 2010.
This document and the contents/images are for demonstration to the intended client only and its contents are not to be disclosed to any third party without.
Certificates of Confidentiality:
Project Management: Messages
Patient Biospecimen Preanalytics:
GW AIDS and Cancer Specimen Resource
Angela J Waanders, MD, MPH The Children’s Hospital of Philadelphia
Strength of Evidence; Empirically Supported Treatments
Chapter 7 T. Trimpe DNA Analysis Chapter 7 T. Trimpe
A Patient has the Right to…..
CONDUCTING THE TRIAL AT
Chemical Purchasing.
Clinic Management System(CMS)
Medical Lab.
If the testing required has yet to be decided, or the sample may be required in the future please tick this box to store DNA. Please provide as many.
SYNOPSIS OF THE PROTOCOL
Epic Tools for Clinical Research
Special Considerations in Genetic Research
Basic Data Provenance April 22, 2019
Epic Tools for Clinical Research
Presentation transcript:

Specimen Model Project: Requirements from Clinical Genomics Mukesh Sharma Washington University Medical School St. Louis October 2010 WG meeting

AgendaAgenda Scope Requirements represented in specimen CMET Requirements not represented in specimen CMET

ScopeScope Project will detail specimen collection, procedure(s) done on specimen and specimen storage that will affect the quality of the specimen.

Requirements Represented In Specimen CMET Specimen Handling and Processing Special handling such as flash freezing Type of preservatives used and amount. Examples: additives used to preserve RNA/DNA –In the current model, Specimen is associated to Entity Choice Box and Entity is related to ContainerOrAdditive Choice Box. Storage Type of storage used for collected specimen and any genetic extracted material. Specimen Access Unique identifiers assigned to all materials (both collected and derived) to help manage access to specimens.

Requirements Represented In Specimen CMET Specimen Type Whether fluid, tissue, cell or molecular specimen? –Molecular Specimen can be derived from any of the other 3 types of specimens –Cell specimens can be derived from fluid and tissue specimens –In the Specimen model, Natural.code is available to capture type of specimen and DerivedSpecimen class to capture derived specimens Specimen Quantity Quantity and/or size of specimen collected. –In the Specimen model, Natural class is available to capture this information Specimen Characteristics Anatomical location/tissue site from where specimens were obtained –In the Specimen model, SpecimenCollectionProcess.targetSiteCode and SpecimenCollectionProcess.approachSiteCode is available to capture this information

Requirements Represented In Specimen CMET Specimen Processing Sample processing immediately after collection and stored on site. –Requirement includes intermediate processing and specimen types prior to generating genetic material (e.g. PBMC extraction, aliquots, resection) –Will the effectiveTime attribute in the SpecimenCollectionProcess and SpecimenProcessStep capture the information about when the specimen was collected and processed respectively? Specimen Characteristics RNA/DNA characteristics: e.g. Purity values-A260/A230 and A260/A280, RNA integrity number (RIN) number etc. –Not in the CMET –QC needs to be done by the specimen core lab –Check with O&O if this will be captured by SpecimenProcessStep (QC process step)? –Is the readings of A260/A280 is captured in ObservationEvent?

Requirements Not Represented In Specimen CMET 1. Genetic Consent Form Linking up with the Genetic Consent Form. –Form signed by the patient to allow genetic/genomic testing and in some cases to permit long-term storage of genetic samples for further research. –Need to know that there is consent; duration that it allows the specimen to be used for (indefinite or restricted to particular duration or protocols). –Consent could be withdrawn and as a result the specimen is pulled out and destroyed. –Suggested Action –Will add association to the consent class (from CDA model) and add attributes to the consent class to manage specimen (attributes needed are consent active or not -withdrawn consent). –The low priority task/future work would be to design a consent document based on existing documents. We will review type of consent in various settings (clinical trial, Health Care Enterprise [IHE] organization, other Standard Development Organizations).

Requirements Not Represented In Specimen CMET 2. Specimen Management –Specimen Collection –Two use cases: i) Patient comes in and we take 2 or more specimens ii) Patient comes in and we take 1 specimen –We need to capture the relationship between multiple specimens collected at one time (use case i) –The universal CMET only has one entry point (SpecimenChoice) i.e. all CMETs are starting from Specimen – Suggested Action –In the SpecimenChoice Box add the SpecimenCollectionGroup class (especially for use case i)

Requirements Not Represented In Specimen CMET Current ModelProposed Change

Requirements Not Represented In Specimen CMET 3. Transportation Specimen Sender and Receiver –Capture when specimen was sent to lab and when received by the other lab –Capture information about the transportation vessel etc. –Not currently available in the CMET …..but the note for SpecimenProcessStep class says that it captures event as Specimen Received in lab. This class also captures specimen aliquoting, specimen treatment etc. Suggested Action –Add a sender and receiver as classes –Classes to have time stamp attribute –Other details to capture: site to lab or lab to lab transportation. transportation container, transportation vessel, transportation vehicle etc.

AcknowledgementsAcknowledgements Austin J. Kreisler and The Clinical Genomics Work group